دورية أكاديمية
أعرض في EDS

Interrelationships between tuberculosis and chronic obstructive pulmonary disease.

التفاصيل البيبلوغرافية
العنوان: Interrelationships between tuberculosis and chronic obstructive pulmonary disease.
المؤلفون: Zavala MJ; Division of Pulmonary and Critical Care Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Becker GL, Blount RJ
المصدر: Current opinion in pulmonary medicine [Curr Opin Pulm Med] 2023 Mar 01; Vol. 29 (2), pp. 104-111. Date of Electronic Publication: 2023 Jan 17.
نوع المنشور: Review; Journal Article; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9503765 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-6971 (Electronic) Linking ISSN: 10705287 NLM ISO Abbreviation: Curr Opin Pulm Med Subsets: MEDLINE
أسماء مطبوعة: Publication: Philadelphia, PA : Lippincott Williams & Wilkins
Original Publication: Philadelphia, PA : Current Science, c1995-
مواضيع طبية MeSH: Pulmonary Disease, Chronic Obstructive* , Tuberculosis*/epidemiology , Air Pollution*, Humans ; Prospective Studies ; Risk Factors
مستخلص: Purpose of Review: Our objective was to review the current literature regarding socioeconomic, environmental, clinical, and immunologic factors common to chronic obstructive pulmonary disease (COPD) and tuberculosis (TB).
Recent Findings: Recent studies suggest that TB patients might be at increased risk for developing COPD. Conversely, additional prospective cohort studies have determined that COPD patients are at increased risk for active TB: a risk that appears to be partially mediated through inhaled corticosteroid use. Tobacco smoking, poverty, air pollution, and malnutrition are associated with COPD and TB. Vitamin D has been shown to prevent COPD exacerbations, but its use for preventing TB infection remains unclear. Surfactant deficiency, elevated matrix metalloproteinases, and toll-like receptor 4 polymorphisms play key roles in the pathogenesis of both diseases.
Summary: Recent studies have elucidated interrelationships between COPD and TB. Future research is needed to optimize clinical and public health approaches that could mitigate risk factors contributing to both diseases.
(Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
References: Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 390:1151–1210.
World Health Organization (WHO) Chronic obstructive pulmonary disease (COPD), Fact sheet December 2022. 2022 [cited 9 September 2022]. Available at: https://www.who.int/en/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease - (COPD). [Accessed 9 September 2022].
World Health Organization (WHO) Global tuberculosis report 2021. [Internet]. 2022 [cited Sep. 2nd, 2022]. Available at: https://www.who.int/publications/i/item/9789240037021 . [Accessed 2 September 2022].
Celli BR, Wedzicha JA. Update on clinical aspects of chronic obstructive pulmonary disease. New Engl J Med 2019; 381:1257–1266.
Maguire G, Anstey N, Ardian M, et al. Pulmonary tuberculosis, impaired lung function, disability and quality of life in a high-burden setting. Int J Tuberc Lung Dis 2009; 13:1500–1506.
Mbatchou Ngahane BH, Nouyep J, Nganda Motto M, et al. Posttuberculous lung function impairment in a tuberculosis reference clinic in Cameroon. Respir Med 2016; 114:67–71.
Singla R, Mallick M, Mrigpuri P, et al. Sequelae of pulmonary multidrug-resistant tuberculosis at the completion of treatment. Lung India 2018; 35:4–8.
Fan H, Wu F, Liu J, et al. Pulmonary tuberculosis as a risk factor for chronic obstructive pulmonary disease: a systematic review and meta-analysis. Ann Transl Med 2021; 9:390.
Abdelaleem NA, Ahmed MK, Mohamed MN, Bayoumi HA. Lung health after tuberculosis: clinical and functional assessment in postpulmonary tuberculosis Egyptian patients. Egypt J Bronchol 2022; 16:23.
Nightingale R, Chinoko B, Lesosky M, et al. Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study. Thorax 2021; 77:thoraxjnl-2021-217190.
Hamada Y, Fong CJ, Copas A, et al. Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence. Transact Royal Soc Trop Med Hygiene 2021; 116:390–398.
O’Toole RF, Shukla SD, Walters EH. TB meets COPD: an emerging global co-morbidity in human lung disease. Tuberculosis 2015; 95:659–663.
Benfield T, Lange P, Vestbo J. COPD stage and risk of hospitalization for infectious disease. Chest 2008; 134:46–53.
Inghammar M, Ekbom A, Engström G, et al. COPD and the risk of tuberculosis--a population-based cohort study. PLOS One 2010; 5:e10138.
Lee C-H, Lee M-C, Shu C-C, et al. Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study. BMC Infect Dis 2013; 13:194.
Postma DS, Bush A, van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet 2015; 385:899–909.
Cohen BH, Ball WC Jr, Brashears S, et al. Risk factors in chronic obstructive pulmonary disease (COPD). Am J Epidemiol 1977; 105:223–232.
Bates MN, Khalakdina A, Pai M, et al. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007; 167:335–342.
Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med 2007; 4:e20.
Horne DJ, Campo M, Ortiz JR, et al. Association between smoking and latent tuberculosis in the U.S. population: an analysis of the National Health and Nutrition Examination Survey. PLoS One 2012; 7:e49050.
Jee SH, Golub JE, Jo J, et al. Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol 2009; 170:1478–1485.
Maciel EL, Brioschi AP, Peres RL, et al. Smoking and 2-month culture conversion during antituberculosis treatment. Int J Tuberc Lung Dis 2013; 17:225–228.
Slama K, Chiang CY, Enarson DA, et al. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 2007; 11:1049–1061.
Patra J, Bhatia M, Suraweera W, et al. Exposure to second-hand smoke and the risk of tuberculosis in children and adults: a systematic review and meta-analysis of 18 observational studies. PLoS Med 2015; 12:e1001835.
Ganmaa D, Khudyakov P, Buyanjargal U, et al. Prevalence and determinants of QuantiFERON-diagnosed tuberculosis infection in 9810 Mongolian schoolchildren. Clin Infect Dis 2019; 69:813–819.
Lindsay RP, Shin SS, Garfein RS, et al. The association between active and passive smoking and latent tuberculosis infection in adults and children in the United States: results from NHANES. PLoS One 2014; 9:e93137.
Dogar OF, Pillai N, Safdar N, et al. Second-hand smoke and the risk of tuberculosis: a systematic review and a meta-analysis. Epidemiol Infect 2015; 143:3158–3172.
Blount RJ, Phan H, Trinh T, et al. Indoor Air Pollution and Susceptibility to Tuberculosis Infection in Urban Vietnamese Children. Am J Respir Crit Care Med 2021; 204:1211–1221.
The GATS (Global Adult Tobacco Survey) [Internet]. 2021 [cited Sep. 9th, 2022]. Available at: https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/global-adult-tobacco-survey . [Accessed 9 September 2022].
Louwagie GM, Okuyemi KS, Ayo-Yusuf OA. Efficacy of brief motivational interviewing on smoking cessation at tuberculosis clinics in Tshwane, South Africa: a randomized controlled trial. Addiction 2014; 109:1942–1952.
Lin H, Lin Y, Xiao L, et al. How do smoking status and smoking cessation efforts affect tb recurrence after successful completion of anti-TB treatment? A multicenter, prospective cohort study with a 7-year follow-up in China. Nicotine Tob Res 2021; 23:1995–2002.
Navya N, Jeyashree K, Madhukeshwar AK, et al. Are they there yet? Linkage of patients with tuberculosis to services for tobacco cessation and alcohol abuse - a mixed methods study from Karnataka, India. BMC Health Serv Res 2019; 19:90.
Moutinho S. Tuberculosis is the oldest pandemic, and poverty makes it continue. Nature 2022; 605:S16–S20.
Hung CL, Chien JY, Ou CY. Associated factors for tuberculosis recurrence in Taiwan: a nationwide nested case-control study from 1998 to 2010. PLoS One 2015; 10:e0124822.
Hudelson P. Gender differentials in tuberculosis: the role of socio-economic and cultural factors. Tuber Lung Dis 1996; 77:391–400.
Lönnroth K, Jaramillo E, Williams BG, et al. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009; 68:2240–2246.
Cantwell MF, McKenna MT, McCray E, Onorato IM. Tuberculosis and race/ethnicity in the United States: impact of socioeconomic status. Am J Respir Crit Care Med 1998; 157 (4 pt 1):1016–1020.
Zhang DD, Liu JN, Ye Q, et al. Association between socioeconomic status and chronic obstructive pulmonary disease in Jiangsu province, China: a population-based study. Chin Med J (Engl) 2021; 134:1552–1560.
Gershon AS, Hwee J, Victor JC, et al. Trends in socioeconomic status–related differences in mortality among people with chronic obstructive pulmonary disease. Ann Am Thorac Soc 2014; 11:1195–1202.
Park J, Kim HJ, Lee CH, et al. Impact of long-term exposure to ambient air pollution on the incidence of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Environ Res 2021; 194:110703.
Jaganath D, Miranda JJ, Gilman RH, et al. CRONICAS Cohort Study Group. Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru. Respir Res 2015; 16:40.
Akhtar T, Ullah Z, Khan MH, Nazli R. Chronic bronchitis in women using solid biomass fuel in rural Peshawar, Pakistan. Chest 2007; 132:1472–1475.
Albers AE, Pope K, Sijali TR, et al. Household fuel use and latent tuberculosis infection in a Nepali population. Environ Res 2019; 173:69–76.
Hystad P, Duong M, Brauer M, et al. [on behalf of Prospective Urban and Rural Epidemiological (PURE) Study investigators]. Health effects of household solid fuel use: findings from 11 countries within the prospective urban and rural epidemiology study. Environ Health Perspect 2019; 127:57003.
Patel V, Foster A, Salem A, et al. Long-term exposure to indoor air pollution and risk of tuberculosis. Indoor Air 2021; 31:628–638.
Checkley W, Williams KN, Kephart JL, et al. CHAP Trial Investigators. Effects of a household air pollution intervention with liquefied petroleum gas on cardiopulmonary outcomes in Peru. A randomized controlled trial. Am J Respir Crit Care Med 2021; 203:1386–1397.
Kephart JL, Fandiño-Del-Rio M, Williams KN, et al. Nitrogen dioxide exposures from LPG stoves in a cleaner-cooking intervention trial. Environ Int 2021; 146:106196.
Niu Z, Qi Y, Zhao P, et al. Short-term effects of ambient air pollution and meteorological factors on tuberculosis in semi-arid area, northwest China: a case study in Lanzhou. Environ Sci Pollut Res Int 2021; 28:69190–69199.
Dimala CA, Kadia BM. A systematic review and meta-analysis on the association between ambient air pollution and pulmonary tuberculosis. Sci Rep 2022; 12:11282.
Blount RJ, Pascopella L, Catanzaro DG, et al. Traffic-related air pollution and all-cause mortality during tuberculosis treatment in California. Environ Health Perspect 2017; 125:097026.
Blount RJ, Pascopella L, Barry P, et al. Residential urban tree canopy is associated with decreased mortality during tuberculosis treatment in California. Sci Total Environ 2020; 711:134580.
Lönnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol 2010; 39:149–155.
Prescott E, Almdal T, Mikkelsen KL, et al. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002; 20:539–544.
Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173:79–83.
Guo Y, Zhang T, Wang Z, et al. Body mass index and mortality in chronic obstructive pulmonary disease: A dose-response meta-analysis. Medicine (Baltimore) 2016; 95:e4225.
McDonald MN, Wouters EFM, Rutten E, et al. It's more than low BMI: prevalence of cachexia and associated mortality in COPD. Respir Res 2019; 20:100.
Marco E, Sánchez-Rodríguez D, Dávalos-Yerovi VN, et al. Malnutrition according to ESPEN consensus predicts hospitalizations and long-term mortality in rehabilitation patients with stable chronic obstructive pulmonary disease. Clin Nutr 2019; 38:2180–2186.
Birlie A, Tesfaw G, Dejene T, Woldemichael K. Time to death and associated factors among tuberculosis patients in Dangila Woreda, Northwest Ethiopia. PLoS One 2015; 10:e0144244.
Peetluk LS, Rebeiro PF, Cordeiro-Santos M, et al. Lack of Weight gain during the first 2 months of treatment and human immunodeficiency virus independently predict unsuccessful treatment outcomes in tuberculosis. J Infect Dis 2020; 221:1416–1424.
Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr 2012; 95:1385–1395.
Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012; 12:CD000998.
Bernardes S, Eckert IC, Burgel CF, et al. Increased energy and/or protein intake improves anthropometry and muscle strength in COPD patients: a systematic review with meta-analysis on randomized controlled clinical trials. Br J Nutr 2022; 1–55.
Sinclair D, Abba K, Grobler L, Sudarsanam TD. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev 2011; (11):CD006086.
Yen YF, Hu HY, Lee YL, et al. Obesity/overweight reduces the risk of active tuberculosis: a nationwide population-based cohort study in Taiwan. Int J Obes (Lond) 2017; 41:971–975.
Lin HH, Wu CY, Wang CH, et al. Association of obesity, diabetes, and risk of tuberculosis: two population-based cohorts. Clin Infect Dis 2018; 66:699–705.
Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373:1083–1096.
Lambert AA, Putcha N, Drummond MB, et al. COPDGene Investigators. Obesity is associated with increased morbidity in moderate to severe COPD. Chest 2017; 151:68–77.
Yamauchi Y, Hasegawa W, Yasunaga H, et al. Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan. Int J Chron Obstruct Pulmon Dis 2014; 9:1337–1346.
Cao C, Wang R, Wang J, et al. Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS One 2012; 7:e43892.
Spelta F, Fratta Pasini AM, Cazzoletti L, Ferrari M. Body weight and mortality in COPD: focus on the obesity paradox. Eating and weight disorders - studies on anorexia, bulimia and obesity 2018; 23:15–22.
Suzuki M, Makita H, Ito YM, et al. Hokkaido COPD Cohort Study Investigators. Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study. Eur Respir J 2014; 43:1289–1297.
Wei YF, Tsai YH, Wang CC, Kuo PH. Impact of overweight and obesity on acute exacerbations of COPD - subgroup analysis of the Taiwan Obstructive Lung Disease cohort. Int J Chron Obstruct Pulmon Dis 2017; 12:2723–2729.
Jo YS, Kim YH, Lee JY, et al. Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction. Int J Chron Obstruct Pulmon Dis 2018; 13:2261–2269.
Smulders L, van der Aalst A, Neuhaus E, et al. Decreased risk of COPD exacerbations in obese patients. COPD 2020; 17:485–491.
Brigham EP, Anderson JA, Brook RD, et al. Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial. ERJ Open Res 2021; 7:00902–2020.
Castellana G, Castellana M, Castellana C, et al. Inhaled corticosteroids and risk of tuberculosis in patients with obstructive lung diseases: a systematic review and meta-analysis of nonrandomized studies. Int J Chron Obstruct Pulmon Dis 2019; 14:2219–2227.
Huang TM, Kuo KC, Wang YH, et al. Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids. BMC Infect Dis 2020; 20:706.
Yu I, Park S, Hong S, et al. Risk of tuberculosis caused by fluticasone propionate versus budesonide in chronic obstructive pulmonary disease: a nationwide population-based study. J Pers Med 2022; 12:1189.
Kafle S, Basnet AK, Karki K, et al. Association of vitamin D deficiency with pulmonary tuberculosis: a systematic review and meta-analysis. Cureus 2021; 13:e17883.
McArdle AJ, Keane D, Seddon JA, et al. Vitamin D deficiency is associated with tuberculosis disease in British children. Int J Tuberc Lung Dis 2020; 24:782–788.
Conesa-Botella A, Goovaerts O, Massinga Loembe M, et al. TB IRIS Study Group. Low prevalence of vitamin D deficiency in Ugandan HIV-infected patients with and without tuberculosis. Int J Tuberc Lung Dis 2012; 16:1517–1521.
Musarurwa C, Zijenah L, Duri D, et al. Association of high serum vitamin D concentrations with active pulmonary TB in an HIV co-endemic setting, Harare, Zimbabwe. BMC Infect Dis 2017; 17:142.
Musarurwa C, Zijenah L, Mhandire D, et al. Higher serum 25-hydroxyvitamin D concentrations are associated with active pulmonary tuberculosis in hospitalised HIV infected patients in a low income tropical setting: a cross sectional study. BMC Pulm Med 2018; 18:67.
Owolabi O, Agbla S, Owiafe P, et al. Elevated serum 25-hydroxy (OH) vitamin D levels are associated with risk of TB progression in Gambian adults. Tuberculosis (Edinb) 2016; 98:86–91.
Martinez L, Ncayiyana JR, Goddard E, et al. Vitamin D concentrations in infancy and the risk of tuberculosis disease in childhood: a prospective birth cohort in Cape Town, South Africa. Clin Infect Dis 2022; 74:2036–2043.
Coussens AK, Martineau AR, Wilkinson RJ. Anti-inflammatory and antimicrobial actions of vitamin D in combating TB/HIV. Scientifica (Cairo) 2014; 2014:903680.
Stapleton EM, Keck K, Windisch R, et al. Vitamin D-mediated effects on airway innate immunity in vitro. PLoS One 2022; 17:e0269647.
Ganmaa D, Uyanga B, Zhou X, et al. Vitamin D supplements for prevention of tuberculosis infection and disease. N Engl J Med 2020; 383:359–368.
Burkes RM, Ceppe AS, Doerschuk CM, et al. Associations among 25-hydroxyvitamin D levels, lung function, and exacerbation outcomes in COPD: an analysis of the SPIROMICS Cohort. Chest 2020; 157:856–865.
Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials. Thorax 2019; 74:337–345.
Moré JM, Voelker DR, Silveira LJ, et al. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease. BMC Pulm Med 2010; 10:53.
Honda Y, Takahashi H, Kuroki Y, et al. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 1996; 109:1006–1009.
Agudelo CW, Kumley BK, Area-Gomez E, et al. Decreased surfactant lipids correlate with lung function in chronic obstructive pulmonary disease (COPD). PLoS One 2020; 15:e0228279.
Ferguson JS, Voelker DR, McCormack FX, Schlesinger LS. Surfactant protein D binds to Mycobacterium tuberculosis Bacilli and Lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J Immunol 1999; 163:312.
Hsieh MH, Ou CY, Hsieh WY, et al. Functional analysis of genetic variations in surfactant protein D in mycobacterial infection and their association with tuberculosis. Front Immunol 2018; 9:1543.
Belton M, Brilha S, Manavaki R, et al. Hypoxia and tissue destruction in pulmonary TB. Thorax 2016; 71:1145–1153.
Abd El-Fatah MF, Ghazy MA, Mostafa MS, et al. Identification of MMP-9 as a biomarker for detecting progression of chronic obstructive pulmonary disease. Biochem Cell Biol 2015; 93:541–547.
Bchir S, Ben Nasr H, Garrouch A, et al. MMP-3 (-1171 5A/6A; Lys45Glu) variants affect serum levels of matrix metalloproteinase (MMP)-3 and correlate with severity of COPD: A study of MMP-3, MMP-7 and MMP-12 in a Tunisian population. J Gene Med 2018; 20:e2999.
Dai Y, Zhang Z, Xu L, et al. Genetic polymorphisms of IL17A, TLR4 and P2RX7 and associations with the risk of chronic obstructive pulmonary disease. Mutat Res Genet Toxicol Environ Mutage 2018; 829-830:1–5.
Li Z, Mao X, Liu Q, et al. Functional variations of the TLR4 gene in association with chronic obstructive pulmonary disease and pulmonary tuberculosis. BMC Pulm Med 2019; 19:184.
معلومات مُعتمدة: K23 ES025807 United States ES NIEHS NIH HHS; P30 ES005605 United States ES NIEHS NIH HHS
تواريخ الأحداث: Date Created: 20230117 Date Completed: 20230127 Latest Revision: 20240302
رمز التحديث: 20240302
مُعرف محوري في PubMed: PMC9877200
DOI: 10.1097/MCP.0000000000000938
PMID: 36647566
قاعدة البيانات: MEDLINE
الوصف
تدمد:1531-6971
DOI:10.1097/MCP.0000000000000938